Qingyi Meng

486 total citations
23 papers, 386 citations indexed

About

Qingyi Meng is a scholar working on Epidemiology, Surgery and Molecular Biology. According to data from OpenAlex, Qingyi Meng has authored 23 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Qingyi Meng's work include Liver Disease and Transplantation (4 papers), Tuberculosis Research and Epidemiology (2 papers) and Cancer Research and Treatments (2 papers). Qingyi Meng is often cited by papers focused on Liver Disease and Transplantation (4 papers), Tuberculosis Research and Epidemiology (2 papers) and Cancer Research and Treatments (2 papers). Qingyi Meng collaborates with scholars based in China, United States and Malaysia. Qingyi Meng's co-authors include Hong Lai, João A.C. Lima, David D. Celentano, David Vlahov, Nianfeng Sun, Kenrad E. Nelson, Wenjing Tong, Steffanie A. Strathdee, Shenghan Lai and Ruihua Wang and has published in prestigious journals such as The American Journal of Cardiology, European Journal of Pharmacology and American Heart Journal.

In The Last Decade

Qingyi Meng

21 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyi Meng China 13 132 77 73 70 68 23 386
Chlebowski Rt United States 7 109 0.8× 60 0.8× 27 0.4× 44 0.6× 25 0.4× 11 388
S. Eralp Bellibas United States 10 29 0.2× 45 0.6× 88 1.2× 154 2.2× 43 0.6× 22 380
J. Capeau France 10 379 2.9× 200 2.6× 46 0.6× 288 4.1× 19 0.3× 22 731
Neil Reynolds United Kingdom 10 11 0.1× 55 0.7× 47 0.6× 59 0.8× 25 0.4× 15 352
Keren Mahlab‐Guri Israel 8 43 0.3× 24 0.3× 20 0.3× 51 0.7× 30 0.4× 26 264
Anna Parfieniuk‐Kowerda Poland 12 38 0.3× 71 0.9× 39 0.5× 151 2.2× 7 0.1× 61 490
JH Beijnen Netherlands 11 24 0.2× 78 1.0× 20 0.3× 91 1.3× 10 0.1× 15 364
A. Verbruggen Belgium 11 26 0.2× 71 0.9× 62 0.8× 18 0.3× 21 0.3× 36 336
Nelson Ja United States 10 33 0.3× 97 1.3× 152 2.1× 46 0.7× 5 0.1× 28 450
Jianhui Fan China 11 22 0.2× 102 1.3× 49 0.7× 44 0.6× 4 0.1× 23 446

Countries citing papers authored by Qingyi Meng

Since Specialization
Citations

This map shows the geographic impact of Qingyi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyi Meng more than expected).

Fields of papers citing papers by Qingyi Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyi Meng. The network helps show where Qingyi Meng may publish in the future.

Co-authorship network of co-authors of Qingyi Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyi Meng. A scholar is included among the top collaborators of Qingyi Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyi Meng. Qingyi Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Qingyi, Hongye Lu, Guangbiao Xu, et al.. (2025). Ultrafine glass fiber modified with hierarchical micro/nano structure for refined dehydration from petroleum products. Separation and Purification Technology. 376. 134096–134096.
2.
Wang, Guili, et al.. (2024). Sequencing of messenger RNA in the healing process of diabetes foot ulcer. Frontiers in Endocrinology. 15. 1468301–1468301.
3.
Zhang, Lingling, et al.. (2019). Efficacy of Endovenous Laser Treatment Combined with Sclerosing Foam in Treating Varicose Veins of the Lower Extremities. Advances in Therapy. 36(9). 2463–2474. 8 indexed citations
4.
Meng, Qingyi, et al.. (2017). Cannabidiol administration reduces sublesional cancellous bone loss in rats with severe spinal cord injury. European Journal of Pharmacology. 809. 13–19. 27 indexed citations
5.
Wang, Rongfei & Qingyi Meng. (2016). Nanoparticle-mediated arresten gene inhibits neointimal formation of vein grafts: an experimental research. Journal of Thoracic Disease. 8(11). 3081–3086. 3 indexed citations
6.
Meng, Qingyi, et al.. (2015). [China Expert Consensus of Medical Emergency Rescue for acute poisoning accidents in 2015].. PubMed. 27(8). 625–9. 2 indexed citations
7.
Zhang, Jun, et al.. (2015). Reduced cortisol in the absence of bacterial infection in patients with hepatitis B virus cirrhosis. Genetics and Molecular Research. 14(3). 7957–7963. 2 indexed citations
8.
Mao, Liufeng, Dengfeng Xu, Ling Yang, et al.. (2015). C-Aryl glucoside SGLT2 inhibitors containing a biphenyl motif as potential anti-diabetic agents. Bioorganic & Medicinal Chemistry Letters. 25(14). 2744–2748. 22 indexed citations
9.
Wang, Ruihua, et al.. (2013). Treatment of Budd-Chiari syndrome with inferior vena cava thrombosis. Experimental and Therapeutic Medicine. 5(4). 1254–1258. 16 indexed citations
10.
Meng, Qingyi, et al.. (2012). Random amphiphilic copolymeric sub-micro particles as a carrier shielding from enzymatic attack for peptides and proteins delivery. Journal of Materials Science Materials in Medicine. 23(4). 991–998. 3 indexed citations
11.
Meng, Qingyi, Zhiqiang Zou, Yujie Fan, et al.. (2011). Correlation between promoter methylation of glutathione‐S‐tranferase P1 and oxidative stress in acute‐on‐chronic hepatitis B liver failure. Journal of Viral Hepatitis. 18(7). e226–31. 14 indexed citations
12.
Sun, Nianfeng, Qingyi Meng, Sanyuan Hu, et al.. (2011). Correlation between the expression of the BAG-1 gene and clinicopathologic factors in colorectal cancer. Journal of Cancer Research and Clinical Oncology. 137(10). 1419–1424. 4 indexed citations
13.
Meng, Qingyi, et al.. (2011). Endovascular treatment of Budd-Chiari syndrome.. PubMed. 124(20). 3289–92. 19 indexed citations
14.
Sun, Nianfeng, et al.. (2011). Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: In vitro and in vivo evaluation. Cancer Letters. 315(1). 69–77. 23 indexed citations
15.
Sun, Nianfeng, Qingyi Meng, & Ailing Tian. (2010). Expressions of the anti-apoptotic genes Bag-1 and Bcl-2 in colon cancer and their relationship. The American Journal of Surgery. 200(3). 341–345. 21 indexed citations
16.
Meng, Qingyi, et al.. (2009). Synthesis and evaluation of carbamate prodrugs of SQ109 as antituberculosis agents. Bioorganic & Medicinal Chemistry Letters. 19(10). 2808–2810. 19 indexed citations
17.
Meng, Qingyi, et al.. (2009). Synthesis of novel [1,2]-diamines with antituberculosis activity. Bioorganic & Medicinal Chemistry Letters. 19(18). 5372–5375. 16 indexed citations
18.
Meng, Qingyi, João A.C. Lima, Hong Lai, et al.. (2003). Elevated C-reactive protein levels are associated with endothelial dysfunction in chronic cocaine users. International Journal of Cardiology. 88(2-3). 191–198. 22 indexed citations
19.
Lai, Shenghan, Hong Lai, Qingyi Meng, et al.. (2002). Effect of cocaine use on coronary calcium among black adults in Baltimore, Maryland. The American Journal of Cardiology. 90(3). 326–328. 32 indexed citations
20.
Meng, Qingyi, João A.C. Lima, Hong Lai, et al.. (2002). Use of HIV Protease Inhibitors Is Associated With Left Ventricular Morphologic Changes and Diastolic Dysfunction. JAIDS Journal of Acquired Immune Deficiency Syndromes. 30(3). 306–310. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chlebowski Rt Breakdown of academic impact, for papers by S. Eralp Bellibas Breakdown of academic impact, for papers by J. Capeau Breakdown of academic impact, for papers by Neil Reynolds Breakdown of academic impact, for papers by Keren Mahlab‐Guri Breakdown of academic impact, for papers by Anna Parfieniuk‐Kowerda Breakdown of academic impact, for papers by JH Beijnen Breakdown of academic impact, for papers by A. Verbruggen Breakdown of academic impact, for papers by Nelson Ja Breakdown of academic impact, for papers by Jianhui Fan
Rankless by CCL
2026